Article

Pharmacological Treatments for Obsessive Compulsive Disorder

Darin D. Dougherty, Scott L. Rauch and Michael A. Jenike

in The Oxford Handbook of Obsessive Compulsive and Spectrum Disorders

Published in print August 2011 | ISBN: 9780195376210
Published online September 2012 | | DOI: http://dx.doi.org/10.1093/oxfordhb/9780195376210.013.0061

Series: Oxford Library of Psychology

 Pharmacological Treatments for Obsessive Compulsive Disorder

Show Summary Details

Preview

Progress in treating OCD has accelerated in recent years. Effective first-line treatments include behavior therapy and medications, with overwhelming evidence supporting the efficacy of serotonergic reuptake inhibitors (SRIs). Second-line medication treatments for OCD include augmentation of SRIs with neuroleptics, clonazepam, or buspirone, with limited support for other strategies at present. Alternative monotherapies (e.g., buspirone, clonazepam, phenelzine) have more limited supporting data and require further study. Behavior therapy, and perhaps cognitive therapy, is as effective as medication and may be superior in risks, costs, and enduring benefits. Future rigorous research is needed to determine which patients respond preferentially to which medications, at what dose, and after what duration. Emerging treatments include new compounds acting via serotonergic, dopaminergic, glutamatergic, and opioid systems.

Keywords: serotonergic reuptake inhibitors; SRI; SSRI; monotherapy; augmentation

Article.  8771 words. 

Subjects: Psychology ; Clinical Psychology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.